AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33860579 — intervention group
Group type: EXPERIMENTAL
Intervention: Taxane/platinum therapy
Number of subjects: 165
Study 36163925 — intervention group
Group type: EXPERIMENTAL
Intervention: asciminib 40 mg twice daily
Number of subjects: 233
Study 36163925 — intervention group
Group type: COMPARATOR
Intervention: bosutinib 500 mg once daily
Number of subjects: 233
Study 34023360 — intervention group
Group type: EXPERIMENTAL
Intervention: ProTaper Universal (PTU)
Number of subjects: 180
Study 34023360 — intervention group
Group type: COMPARATOR
Intervention: ProTaper Gold (PTG)
Number of subjects: 180
Study 34023360 — intervention group
Group type: COMPARATOR
Intervention: Twisted File Adaptive (TFA)
Number of subjects: 180
Study 34023360 — intervention group
Group type: COMPARATOR
Intervention: Reciproc Blue (RB)
Number of subjects: 180
Study 33074552 — intervention group
Group type: EXPERIMENTAL
Intervention: Fetoscopic endoluminal tracheal occlusion (FETO)
Number of subjects: 311
Study 32492087 — intervention group
Group type: EXPERIMENTAL
Intervention: Abrocitinib 200 mg/d
Number of subjects: 391
Study 32492087 — intervention group
Group type: EXPERIMENTAL
Intervention: Abrocitinib 100 mg/d
Number of subjects: 391
Study 32492087 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 391
Study 35691323 — intervention group
Group type: EXPERIMENTAL
Intervention: Ustekinumab (6 mg/kg IV on day 0, then 90 mg SC every 8 weeks)
Number of subjects: 386
Study 35691323 — intervention group
Group type: COMPARATOR
Intervention: Adalimumab (160 mg on day 0, 80 mg at 2 weeks, then 40 mg SC every 2 weeks)
Number of subjects: 386
Study 35691323 — intervention group
Group type: EXPERIMENTAL
Intervention: Ustekinumab
Number of subjects: 386
Study 35691323 — intervention group
Group type: COMPARATOR
Intervention: Adalimumab
Number of subjects: 386
Study 34255718 — intervention group
Group type: EXPERIMENTAL
Intervention: Project EMPOWER (self-guided single-session intervention)
Number of subjects: 301
Study 34255718 — intervention group
Group type: COMPARATOR
Intervention: Informational control (psychoeducational materials and resources)
Number of subjects: 301
Study 36008759 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 1 μg/kg over 10 min (group D1)
Number of subjects: 81
Study 36008759 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 1 μg/kg/h continuous infusion (group D2)
Number of subjects: 81
Study 36008759 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.5 μg/kg over 10 min and 0.5 μg/kg/h continuous infusion (group D3)
Number of subjects: 81
Study 36008759 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal saline) (group C)
Number of subjects: 81
Study 32000820 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral dydrogesterone 10 mg three times daily
Number of subjects: 0
Study 32000820 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 36337054 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular therapy (EVT)
Number of subjects: 247
Study 33630863 — intervention group
Group type: EXPERIMENTAL
Intervention: Stockholm3 Model (S3M) test as a reflex test for PSA ≥ 2 ng/mL
Number of subjects: 0
Study 33630863 — intervention group
Group type: COMPARATOR
Intervention: Stockholm3 Model (S3M) test with reflex thresholds of 1 ng/mL
Number of subjects: 0
Study 33630863 — intervention group
Group type: COMPARATOR
Intervention: Stockholm3 Model (S3M) test with reflex thresholds of 1.5 ng/mL
Number of subjects: 0
Study 33630863 — intervention group
Group type: COMPARATOR
Intervention: PSA test alone
Number of subjects: 0
Study 34816601 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Enhancement Therapy (MET) pretreatment to Dialectical Behaviour Therapy Skills Training (DBT-ST); 4-week group MET pretreatment followed by 12-week DBT-ST
Number of subjects: 45
Study 34816601 — intervention group
Group type: COMPARATOR
Intervention: Dialectical Behaviour Therapy Skills Training (DBT-ST) only; 12-week DBT-ST
Number of subjects: 45
Study 33651341 — intervention group
Group type: EXPERIMENTAL
Intervention: SDZ-ADL
Number of subjects: 818
Study 34100744 — intervention group
Group type: EXPERIMENTAL
Intervention: Gelfoam
Number of subjects: 40
Study 34100744 — intervention group
Group type: COMPARATOR
Intervention: Intratympanic injection
Number of subjects: 40
Study 34100744 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall recovery
Number of subjects: 40
Study 34100744 — intervention group
Group type: EXPERIMENTAL
Intervention: Slight recovery
Number of subjects: 40
Study 34100744 — intervention group
Group type: EXPERIMENTAL
Intervention: Marked recovery
Number of subjects: 40
Study 34100744 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete recovery
Number of subjects: 40
Study 34100744 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse reactions
Number of subjects: 40
Study 34107336 — intervention group
Group type: EXPERIMENTAL
Intervention: Group sizes of 3-10 participants
Number of subjects: 64
Study 34107336 — intervention group
Group type: COMPARATOR
Intervention: Group sizes larger than six
Number of subjects: 64
Study 32044587 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetition Priming (RP)
Number of subjects: 0
Study 32044587 — intervention group
Group type: COMPARATOR
Intervention: Antipriming (AP)
Number of subjects: 0
Study 36131137 — intervention group
Group type: EXPERIMENTAL
Intervention: ILR + 24 h-Holter monitoring
Number of subjects: 25
Study 36131137 — intervention group
Group type: COMPARATOR
Intervention: 24 h-Holter monitoring alone
Number of subjects: 25
Study 33170417 — intervention group
Group type: EXPERIMENTAL
Intervention: Meropenem (MEPM) at 120 mg/kg/day as a 1-h drip infusion 3 times a day
Number of subjects: 99
Study 33170417 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperacillin/tazobactam (PIPC/TAZ) at 360 mg/kg/day as a 1-h drip infusion 4 times a day
Number of subjects: 99
Study 33170417 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperacillin/tazobactam (PIPC/TAZ)
Number of subjects: 99
Study 33170417 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperacillin/tazobactam (PIPC/TAZ) in patients ≥ 15 years of age
Number of subjects: 99
Study 32479686 — intervention group
Group type: EXPERIMENTAL
Intervention: Predialysis chronic kidney disease
Number of subjects: 16655
Study 32479686 — intervention group
Group type: COMPARATOR
Intervention: Non-chronic kidney disease (control group)
Number of subjects: 16655
Study 32479686 — intervention group
Group type: EXPERIMENTAL
Intervention: Predialysis chronic kidney disease with any comorbidity
Number of subjects: 16655
Study 35129469 — intervention group
Group type: EXPERIMENTAL
Intervention: N-Acetyl-Cysteine (NAC) 1200 mg twice-daily for up to 5 days postoperatively
Number of subjects: 33
Study 35129469 — intervention group
Group type: EXPERIMENTAL
Intervention: N-Acetyl-Cysteine (NAC)
Number of subjects: 33
Study 35129469 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 34899429 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic Seizure Therapy (MST)
Number of subjects: 79
Study 34899429 — intervention group
Group type: COMPARATOR
Intervention: Electroconvulsive Therapy (ECT)
Number of subjects: 79
Study 34910624 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep Well! intervention
Number of subjects: 15
Study 34040191 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic testing for FH (n = 160)
Number of subjects: 240
Study 34040191 — intervention group
Group type: COMPARATOR
Intervention: Usual care with lipid testing alone (n = 80)
Number of subjects: 240
Study 34040191 — intervention group
Group type: EXPERIMENTAL
Intervention: Pathogenic variant group
Number of subjects: 240
Study 34040191 — intervention group
Group type: EXPERIMENTAL
Intervention: No pathogenic variant group
Number of subjects: 240
Study 35101523 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral rapamycin (6 mg) prior to IV ketamine (0.5 mg/kg)
Number of subjects: 20
Study 35101523 — intervention group
Group type: COMPARATOR
Intervention: Placebo prior to IV ketamine (0.5 mg/kg)
Number of subjects: 20
Study 33545982 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral nutrition
Number of subjects: 60
Study 33545982 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 60
Study 35980956 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep extension (10 hours of sleep)
Number of subjects: 10
Study 35980956 — intervention group
Group type: COMPARATOR
Intervention: Active recovery session (CON)
Number of subjects: 10
Study 34069369 — intervention group
Group type: EXPERIMENTAL
Intervention: Smart-ring CC feedback
Number of subjects: 0
Study 34069369 — intervention group
Group type: COMPARATOR
Intervention: Non-feedback
Number of subjects: 0
Study 35964909 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (1000 mg, oral, once a day)
Number of subjects: 60
Study 35964909 — intervention group
Group type: COMPARATOR
Intervention: Placebo (oral, once a day)
Number of subjects: 60
Study 33214586 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol group (n=88; receiving a drink with 3 cl alcohol)
Number of subjects: 177
Study 33214586 — intervention group
Group type: COMPARATOR
Intervention: Sober control group (n=89; receiving a drink with just some alcohol drops)
Number of subjects: 177
Study 35926004 — intervention group
Group type: EXPERIMENTAL
Intervention: Tele-rehabilitation program (18 sessions, 3 sessions/week)
Number of subjects: 68
Study 34574572 — intervention group
Group type: EXPERIMENTAL
Intervention: High-impact exercise (HiEx)
Number of subjects: 174
Study 34574572 — intervention group
Group type: EXPERIMENTAL
Intervention: High-impact exercise with various directions (HiExVi)
Number of subjects: 174
Study 34574572 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity interval exercise (HiInEx)
Number of subjects: 174
Study 34574572 — intervention group
Group type: COMPARATOR
Intervention: Sham exercise (ShEx)
Number of subjects: 174
Study 35372024 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS (10 Hz, 2000 stimuli)
Number of subjects: 41
Study 35372024 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 41
Study 33183774 — intervention group
Group type: EXPERIMENTAL
Intervention: CHX conditioning and SB2
Number of subjects: 6
Study 33183774 — intervention group
Group type: EXPERIMENTAL
Intervention: MDP conditioning and SB2
Number of subjects: 6
Study 33183774 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined CHX and MDP conditioning and SB2
Number of subjects: 6
Study 33183774 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct bonding with SBU
Number of subjects: 6
Study 33183774 — intervention group
Group type: EXPERIMENTAL
Intervention: CHX conditioning and SBU
Number of subjects: 6
Study 33183774 — intervention group
Group type: COMPARATOR
Intervention: Direct bonding with SB2
Number of subjects: 6
Study 33183774 — intervention group
Group type: EXPERIMENTAL
Intervention: Water storage for 6 months
Number of subjects: 6
Study 35701782 — intervention group
Group type: EXPERIMENTAL
Intervention: Self video feedback group (SVFG)
Number of subjects: 89
Study 35701782 — intervention group
Group type: EXPERIMENTAL
Intervention: Expert-assisted video feedback group (EVFG)
Number of subjects: 89
Study 32476255 — intervention group
Group type: EXPERIMENTAL
Intervention: linagliptin (5 mg)
Number of subjects: 46
Study 32476255 — intervention group
Group type: COMPARATOR
Intervention: glimepiride (1 mg)
Number of subjects: 46
Study 35329797 — intervention group
Group type: EXPERIMENTAL
Intervention: DiaTOHC
Number of subjects: 93
Study 35329797 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 93
Study 33683177 — intervention group
Group type: EXPERIMENTAL
Intervention: Kangaroo care provided with Sarbebe dress
Number of subjects: 0
Study 33683177 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care without Sarbebe dress)
Number of subjects: 0
Study 33826539 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg daily
Number of subjects: 1005
Study 33826539 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1005
Study 33826539 — intervention group
Group type: EXPERIMENTAL
Intervention: High-sensitivity CRP ≥2 mg/dL
Number of subjects: 1005
Study 33826539 — intervention group
Group type: EXPERIMENTAL
Intervention: Family history of premature coronary artery disease
Number of subjects: 1005
Study 35675108 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visit intervention (n=335)
Number of subjects: 1025
Study 35675108 — intervention group
Group type: EXPERIMENTAL
Intervention: Phone call intervention (n=334)
Number of subjects: 1025
Study 35675108 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (n=356)
Number of subjects: 1025
Study 32507443 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry needling (DN)
Number of subjects: 30
Study 32507443 — intervention group
Group type: COMPARATOR
Intervention: Sham dry needling (sham DN)
Number of subjects: 30
Study 33387165 — intervention group
Group type: EXPERIMENTAL
Intervention: Study without Stress (Cognitive Behavioural Therapy program)
Number of subjects: 56
Study 33387165 — intervention group
Group type: COMPARATOR
Intervention: Usual care condition (Control)
Number of subjects: 56
Study 34666179 — intervention group
Group type: EXPERIMENTAL
Intervention: FLASH Navigation System
Number of subjects: 90
Study 34666179 — intervention group
Group type: COMPARATOR
Intervention: 3D Fluoroscopy Navigation System
Number of subjects: 90
Study 33409558 — intervention group
Group type: EXPERIMENTAL
Intervention: Yfiler™ Plus multiplex kit
Number of subjects: 539
Study 35964947 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-flow anesthesia (Group L)
Number of subjects: 64
Study 35964947 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-flow anesthesia (Group L) in smokers
Number of subjects: 64
Study 35964947 — intervention group
Group type: COMPARATOR
Intervention: High-flow anesthesia (Group H)
Number of subjects: 64
Study 33386797 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacubitril valsartan
Number of subjects: 80
Study 33386797 — intervention group
Group type: COMPARATOR
Intervention: Perindopril
Number of subjects: 80
Study 32546490 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin (750 mg three times daily for 100 days)
Number of subjects: 180
Study 32546490 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study 32546490 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin
Number of subjects: 180
Study 32546490 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin (in those with type I Modic changes)
Number of subjects: 180
Study 35703293 — intervention group
Group type: EXPERIMENTAL
Intervention: C-LIFE (cardiac rehabilitation-based lifestyle program)
Number of subjects: 140
Study 35703293 — intervention group
Group type: EXPERIMENTAL
Intervention: C-LIFE
Number of subjects: 140
Study 35703293 — intervention group
Group type: COMPARATOR
Intervention: SEPA (standardized education and physician advice)
Number of subjects: 140
Study 34410238 — intervention group
Group type: EXPERIMENTAL
Intervention: Role play method (cases)
Number of subjects: 107
Study 34410238 — intervention group
Group type: COMPARATOR
Intervention: Conventional teaching methodology (controls)
Number of subjects: 107
Study 32985509 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality Training (VRT)
Number of subjects: 60
Study 32985509 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensory-Motor Training (SMT)
Number of subjects: 60
Study 32985509 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 60
Study 32985509 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone Morphogenic Proteins (BMP)
Number of subjects: 60
Study 34252378 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (500 mg once daily orally for 14 days) plus standard care
Number of subjects: 292
Study 34252378 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 292
Study 32675483 — intervention group
Group type: EXPERIMENTAL
Intervention: Kono-S anastomosis
Number of subjects: 79
Study 32675483 — intervention group
Group type: COMPARATOR
Intervention: Conventional group
Number of subjects: 79
Study 35788355 — intervention group
Group type: EXPERIMENTAL
Intervention: Rh-endostatin combined with WBRT
Number of subjects: 43
Study 35788355 — intervention group
Group type: COMPARATOR
Intervention: Radiation group (WBRT only)
Number of subjects: 43
Study 33990637 — intervention group
Group type: EXPERIMENTAL
Intervention: Metal Artifact Reduction (MAR) algorithm applied to CT scans
Number of subjects: 30
Study 33990637 — intervention group
Group type: COMPARATOR
Intervention: Original CT scans without MAR
Number of subjects: 30
Study 32859157 — intervention group
Group type: EXPERIMENTAL
Intervention: MARS-intervention (care-as-usual plus the MARS-intervention)
Number of subjects: 0
Study 32859157 — intervention group
Group type: COMPARATOR
Intervention: Care-as-usual (control group)
Number of subjects: 0
Study 616874113 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive non‐randomized programme with a strict vegetarian diet
Number of subjects: 179
Study 616874113 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate randomized trial following a Mediterranean‐style diet
Number of subjects: 179
Study 616874113 — intervention group
Group type: COMPARATOR
Intervention: Control group for intensive programme
Number of subjects: 179
Study 616874113 — intervention group
Group type: COMPARATOR
Intervention: Control group for moderate programme
Number of subjects: 179
Study 35168635 — intervention group
Group type: EXPERIMENTAL
Intervention: Online parent-led intervention
Number of subjects: 1080
Study 35168635 — intervention group
Group type: COMPARATOR
Intervention: Usual school practice
Number of subjects: 1080
Study 34316168 — intervention group
Group type: EXPERIMENTAL
Intervention: Delirium prevention bundle protocol
Number of subjects: 50
Study 34316168 — intervention group
Group type: COMPARATOR
Intervention: Standard of care protocol
Number of subjects: 50
Study 36498611 — intervention group
Group type: EXPERIMENTAL
Intervention: RA.DI.CA splint therapy
Number of subjects: 30
Study 36498611 — intervention group
Group type: COMPARATOR
Intervention: Stabilization splint therapy
Number of subjects: 30
Study 32154887 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol-guided individualized nutritional support to reach protein and energy goals
Number of subjects: 1950
Study 32154887 — intervention group
Group type: COMPARATOR
Intervention: Standard hospital food
Number of subjects: 1950
Study 35366092 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg/kg of caffeine
Number of subjects: 15
Study 35366092 — intervention group
Group type: COMPARATOR
Intervention: 3 mg/kg of cellulose (placebo)
Number of subjects: 15
Study 34010616 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel 75 mg once daily for 24 months
Number of subjects: 5530
Study 34010616 — intervention group
Group type: COMPARATOR
Intervention: Aspirin 100 mg once daily for 24 months
Number of subjects: 5530
Study 32708898 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory feedback
Number of subjects: 31
Study 32708898 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual feedback
Number of subjects: 31
Study 36053958 — intervention group
Group type: EXPERIMENTAL
Intervention: Breastfeeding during OGTT
Number of subjects: 20
Study 36053958 — intervention group
Group type: COMPARATOR
Intervention: Avoiding breastfeeding during OGTT
Number of subjects: 20
Study 32354234 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Flexibility in Aphasia Therapy (CFAT)
Number of subjects: 10
Study 32354234 — intervention group
Group type: COMPARATOR
Intervention: Conventional aphasia therapy
Number of subjects: 10
Study 36250371 — intervention group
Group type: COMPARATOR
Intervention: Probiotic treatment (multi-strain probiotics including Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus rhamnosus, Bifidobacterium breve, Bifidobacterium lactis, Bifidobacterium longum, Streptococcus thermophilus) for 8 weeks.
Number of subjects: 0
Study 36250371 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment for 8 weeks.
Number of subjects: 0
Study 32738599 — intervention group
Group type: EXPERIMENTAL
Intervention: Regimen 1 (IRX-2 cytokines)
Number of subjects: 96
Study 32738599 — intervention group
Group type: COMPARATOR
Intervention: Regimen 2 (Control, without IRX-2 cytokines)
Number of subjects: 96
Study 33988477 — intervention group
Group type: EXPERIMENTAL
Intervention: Marathon shoes (Adidas Adizero 3)
Number of subjects: 5
Study 33988477 — intervention group
Group type: COMPARATOR
Intervention: Track spikes (Nike Zoom Matumbo 3)
Number of subjects: 5
Study 33988477 — intervention group
Group type: EXPERIMENTAL
Intervention: Both shoe conditions
Number of subjects: 5
Study 32205642 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-hour feeding after endoscopic hemostasis
Number of subjects: 209
Study 32205642 — intervention group
Group type: COMPARATOR
Intervention: 48-hour feeding after endoscopic hemostasis
Number of subjects: 209
Study 36404343 — intervention group
Group type: EXPERIMENTAL
Intervention: ATRA-ATO
Number of subjects: 128
Study 33513232 — intervention group
Group type: EXPERIMENTAL
Intervention: Very early mobilization (within 24 hours from stroke onset)
Number of subjects: 6033
Study 33513232 — intervention group
Group type: EXPERIMENTAL
Intervention: Early mobilization (between 24 and 72 hours poststroke)
Number of subjects: 6033
Study 33513232 — intervention group
Group type: COMPARATOR
Intervention: Late mobilization (after 72 hours poststroke)
Number of subjects: 6033
Study 33513232 — intervention group
Group type: EXPERIMENTAL
Intervention: Very early mobilization
Number of subjects: 6033
Study 33513232 — intervention group
Group type: EXPERIMENTAL
Intervention: Early mobilization
Number of subjects: 6033
Study 33513232 — intervention group
Group type: COMPARATOR
Intervention: Late mobilization
Number of subjects: 6033
Study 32149693 — intervention group
Group type: EXPERIMENTAL
Intervention: Resting state EEG functional connectivity measures using Phase-Lag-Index processing algorithm
Number of subjects: 10
Study 32149693 — intervention group
Group type: EXPERIMENTAL
Intervention: Application of regression coefficients to connectivity measures from the test-set
Number of subjects: 10
Study 33724638 — intervention group
Group type: EXPERIMENTAL
Intervention: Ocrelizumab
Number of subjects: 0
Study 33724638 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33724638 — intervention group
Group type: COMPARATOR
Intervention: MSBase registry (real-world cohort)
Number of subjects: 0
Study 33285649 — intervention group
Group type: EXPERIMENTAL
Intervention: Active-assisted robotic therapy (n=6)
Number of subjects: 14
Study 33285649 — intervention group
Group type: COMPARATOR
Intervention: Active-unassisted robotic therapy (n=8)
Number of subjects: 14